Cargando…
Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients
BACKGROUND: Hospitalised COVID-19 patients with underlying cardiovascular disease (CVD) and cardiovascular risk factors appear to be at risk of poor outcome. It is unknown if these patients should be considered a vulnerable group in healthcare delivery and healthcare recommendations during the COVID...
Autores principales: | Jewbali, L. S. D., Hoogervorst-Schilp, J., Belfroid, E., Jansen, C. W., Asselbergs, F. W., Siebelink, H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050809/ https://www.ncbi.nlm.nih.gov/pubmed/33860909 http://dx.doi.org/10.1007/s12471-021-01572-9 |
Ejemplares similares
-
Effect of anticoagulant therapy in COVID-19 patients
por: Tieleman, R. G., et al.
Publicado: (2021) -
Four guidelines on cardiovascular complications and cardiovascular disease, prognosis and treatment in COVID‑19
por: Siebelink, H. J., et al.
Publicado: (2021) -
The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients
por: van Kimmenade, R. R. J., et al.
Publicado: (2021) -
How often and to what extent do admitted COVID-19 patients have signs of cardiac injury?
por: Habets, M. A. W., et al.
Publicado: (2021) -
Cardiac complications in patients hospitalised with COVID-19
por: Linschoten, Marijke, et al.
Publicado: (2020)